Current Vascular Pharmacology

Current Vascular Pharmacology is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lipoproteins and Cardiovascular Health, Antiplatelet Therapy and Cardiovascular Diseases and Diabetes, Cardiovascular Risks, and Lipoproteins, together about 21.8% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research. Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Source: LetPub

Research area (LetPub): Peripheral Vascular Disease

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.34LetPub · 2026-09-13

CiteScore 2026-06

3.6LetPub · 2026-09-13

SJR 2026-06

0.6LetPub · 2026-09-13

SNIP 2026-06

0.54LetPub · 2026-09-13

h-index

54LetPub · 2026-09-13

h-index

81OpenAlex · 2026-10-01

i10-index

900OpenAlex · 2026-10-01

2-year mean citedness

2.33OpenAlex · 2026-10-01

Self-citation rate

8.3%LetPub · 2026-09-13

Share of gold OA articles

6.56%LetPub · 2026-09-13

Volume

Articles per year

43LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

6–12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

Fairly easyLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Bentham Science Publishers B.V.

Country or region

ENGLAND

Language

English

Frequency

Quarterly

Founded

2003

ISSN

1570-1611

Electronic ISSN

1875-6212

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub